Treatment combining RU486 and Ad5IL-12 vector attenuates the growth of experimentally formed prostate tumors and induces changes in the sentinel lymph nodes of mice.

J Transl Med · 2010 · PMC2976733 · PMID 20946663

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While the administration of RU486 alone did appear to slow tumor growth somewhat in comparison to the DL70-3 and PBS controls, this effect did not reach statistical significance over the time course analyzed (the tumor volume for RU486 treatment at 8 weeks averaged 1989 ± 307 mm 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.